# AstraZeneca Pharmaceutical

> AstraZeneca Pharmaceutical is a VC fund in Shanghai backing Biotechnology and Manufacturing. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 5
- Last investment: Mar 2026
- Lead investor: 60%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/astrazeneca
- Website: https://www.astrazeneca.com.cn
- Facebook: https://www.facebook.com/pages/category/Business-Service/AstraZeneca-401220407039348/

AstraZeneca Pharmaceutical is a VC fund in Shanghai focused on Biotechnology and Manufacturing. AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to themedical industry Significant changes.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Manufacturing | 2 | 40% |
| Medical Device | 2 | 40% |
| Medical | 1 | 20% |
| Health Diagnostics | 1 | 20% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 40% |
| Series A | 1 | 20% |
| Series D | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Syneron | Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals. | $150M | Series B | Mar 31, 2026 |  |
| Syneron | Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals. | $100M | Series A | Dec 11, 2025 |  |
| Syneron | Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals. |  | Series A | Nov 19, 2024 |  |
| Axbio | Axbio manufactures next-generation gene sequencing and diagnostic high-end equipment and providing complete industrial solutions. | $100M | Series B | Jun 20, 2022 |  |
| Creech Medical Technology Development | Creativity (Beijing) Medical Technology Development Co., Ltd. is a leading minimally invasive interventional delivery system product full solution provider. Committed to cooperating with top experts at home and abroad in the field of minimally invasive intervention, and cooperating with internationally renowned raw material manufacturers to jointlydevelop, produce and sell leading products. Provide doctors with differentiated diagnosis and treatment tools, relieve patients' pain and reduce medical burden. |  | Series D | Dec 22, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [AstraZeneca CICC Medical Industry Fund](https://shizune.co/investors/profile/astrazeneca-cicc-medical-industry-fund) — VC Fund, 2 deals together
- [GL Ventures LLC](https://shizune.co/investors/profile/gl-ventures-llc) — VC Fund, 2 deals together
- [Lenovo Capital and Incubator Group (LCIG)](https://shizune.co/investors/profile/lenovo-capital-and-incubator-group-lcig) — VC Fund, 2 deals together
- [Lilly Asia Ventures](https://shizune.co/investors/profile/lilly-asia-ventures) — VC Fund, 2 deals together
- [5Y Capital](https://shizune.co/investors/profile/morningsidevc) — VC Fund, 2 deals together
- [Sinovation Ventures](https://shizune.co/investors/profile/sinovation-ventures) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does AstraZeneca Pharmaceutical invest in?

AstraZeneca Pharmaceutical invests primarily in Biotechnology, Manufacturing and Medical Device startups, most often at Series B and Series A stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did AstraZeneca Pharmaceutical last invest?

The most recent investment recorded for AstraZeneca Pharmaceutical closed in Mar 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co